Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies-Reference-Cited by-同舟云学术

Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies

Published:2021-09 Issue: Volume:Volume 14 Page:2687-2697
ISSN:1178-7090
Container-title:Journal of Pain Research
language:en
Short-container-title:JPR

Author:

Chamberlain Bruce H,Rhiner Michelle,Slatkin Neal E^ORCID,Stambler Nancy,Israel Robert J

Publisher

Informa UK Limited

Subject

Anesthesiology and Pain Medicine

Reference38 articles.

1. Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis

2. Incidence, Prevalence, and Management of Opioid Bowel Dysfunction

3. The Adverse Effects of Morphine: A Prospective Survey of Common Symptoms During Repeated Dosing for Chronic Cancer Pain

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis;Molecules;2023-11-24

2. Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness;Journal of Pain Research;2023-10

3. Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose;Journal of Pain Research;2023-07

4. Endogenous opiates and behavior: 2021;Peptides;2023-06

5. Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials;Journal of Pain Research;2023-02